This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Respondents currently receiving semaglutide reported that treatment was helping them lose weight, or that it had the potential to help them lose weight, and indicated that its oral administration was preferable to an injection

Pre-existing risk factors for gallstone disease include: Female sex : Women are two to three times more likely to develop gallstones than men, particularly during reproductive years due to hormonal influences Age over 40 years : Gallstone prevalence increases progressively with age Obesity : Higher body mass index correlates with increased gallstone risk, creating a paradox where the condition being treated is itself a risk factor Rapid weight loss history : Previous episodes of quick weight reduction may indicate susceptibility Pregnancy or recent pregnancy : Hormonal changes affect bile composition and gallbladder motility Family history : Genetic factors contribute to gallstone formation Certain ethnicities : Native American and Hispanic populations have higher gallstone prevalence Metabolic syndrome and diabetes : These conditions are associated with altered bile metabolism The rate and magnitude of weight loss during semaglutide treatment significantly influence gallbladder complication risk

It is also rich in vitamins A, C and E that help to increase its antioxidant properties
Analysis of 18 samples on an LC-QTOF platform detected 15,377 peaks, with 2,766 metabolites annotated
You will see results quickly as your body absorbs all the vitamins immediately